• uni logo

QS Rank:

verified

206

uni logo

Queens University of Belfast

flag

Belfast

United Kingdom

PhD projects aim to develop advanced biomaterial-based and implantable drug delivery systems that address key clinical needs in oncology, urology, and chronic pain management. The research integrates pharmaceutical formulation, polymer science, and engineering to create innovative systems for localised, sustained, and controlled drug release. In oncology, the focus is on developing biodegradable and stimuli-responsive implants for site-specific delivery of chemotherapeutics to solid tumors, improving treatment efficacy and minimising systemic toxicity. In urology, projects will explore multifunctional biomaterials for urinary catheters and ureteral stents designed to release antimicrobials or anti-inflammatory agents, reducing infection, biofilm formation, and encrustation. For chronic pain management, our research investigates implantable systems that can provide localised pain relief, decrease systemic opioid use, and improve post-surgical and chronic pain control. Collectively, our research contributes to the next generation of implantable and indwelling systems that improve patient outcomes across multiple therapeutic indications.
intake

Duration

3 Months

Ranking

icon

#295

US World and News Report

icon

#198

The World University Rankings

icon

#206

QS World University Rankings

Class Profile

Application Requirements

Here's everything you need to know to ensure a complete and competitive application—covering the key documents and criteria for a successful submission.

    • intake

      Master SOP

    • intake

      Cover Letter

    Application Deadlines

    Default
    winterJan 16, 2026

    Ready to elevate your study abroad journey?

    Book a call with us now and take the first step towards your global future!

    Connect with us on our social media

    • icon
    • icon
    • icon
    • icon